USD 359.17
(-3.14%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 20.49 Billion USD | 11.11% |
2022 | 18.44 Billion USD | 7.84% |
2021 | 17.1 Billion USD | 19.21% |
2020 | 14.35 Billion USD | -3.58% |
2019 | 14.88 Billion USD | 9.43% |
2018 | 13.6 Billion USD | 9.3% |
2017 | 12.44 Billion USD | 9.88% |
2016 | 11.32 Billion USD | 13.86% |
2015 | 9.94 Billion USD | 2.8% |
2014 | 9.67 Billion USD | 7.25% |
2013 | 9.02 Billion USD | 4.2% |
2012 | 8.65 Billion USD | 4.21% |
2011 | 8.3 Billion USD | 13.48% |
2010 | 7.32 Billion USD | 8.88% |
2009 | 6.72 Billion USD | 0.07% |
2008 | 6.71 Billion USD | 11.96% |
2007 | 6 Billion USD | 11.01% |
2006 | 5.4 Billion USD | 10.96% |
2005 | 4.87 Billion USD | 14.29% |
2004 | 4.26 Billion USD | 17.57% |
2003 | 3.62 Billion USD | 20.38% |
2002 | 3.01 Billion USD | 15.73% |
2001 | 2.6 Billion USD | 13.67% |
2000 | 2.28 Billion USD | 8.83% |
1999 | 2.1 Billion USD | 90.69% |
1998 | 1.1 Billion USD | 12.56% |
1997 | 980.1 Million USD | 7.69% |
1996 | 910.1 Million USD | 4.37% |
1995 | 872 Million USD | 27.88% |
1994 | 681.9 Million USD | 22.36% |
1993 | 557.3 Million USD | 16.81% |
1992 | 477.1 Million USD | 30.78% |
1991 | 364.8 Million USD | 30.01% |
1990 | 280.6 Million USD | 24.21% |
1989 | 225.9 Million USD | 26.48% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 5.24 Billion USD | -9.84% |
2024 Q2 | 5.42 Billion USD | 3.41% |
2024 Q3 | 5.49 Billion USD | 1.33% |
2023 Q2 | 4.99 Billion USD | 4.56% |
2023 Q1 | 4.77 Billion USD | -8.15% |
2023 Q4 | 5.81 Billion USD | 18.46% |
2023 Q3 | 4.9 Billion USD | -1.74% |
2023 FY | 20.49 Billion USD | 11.11% |
2022 Q2 | 4.49 Billion USD | 5.1% |
2022 Q1 | 4.27 Billion USD | -9.06% |
2022 FY | 18.44 Billion USD | 7.84% |
2022 Q3 | 4.47 Billion USD | -0.31% |
2022 Q4 | 5.2 Billion USD | 16.14% |
2021 Q3 | 4.16 Billion USD | -3.12% |
2021 FY | 17.1 Billion USD | 19.21% |
2021 Q2 | 4.29 Billion USD | 8.63% |
2021 Q1 | 3.95 Billion USD | -7.25% |
2021 Q4 | 4.7 Billion USD | 13.0% |
2020 FY | 14.35 Billion USD | -3.58% |
2020 Q2 | 2.76 Billion USD | -22.97% |
2020 Q3 | 3.73 Billion USD | 35.2% |
2020 Q4 | 4.26 Billion USD | 14.05% |
2020 Q1 | 3.58 Billion USD | -13.14% |
2019 FY | 14.88 Billion USD | 9.43% |
2019 Q1 | 3.51 Billion USD | -7.38% |
2019 Q3 | 3.58 Billion USD | -1.73% |
2019 Q2 | 3.65 Billion USD | 3.81% |
2019 Q4 | 4.13 Billion USD | 15.17% |
2018 Q2 | 3.32 Billion USD | 2.5% |
2018 FY | 13.6 Billion USD | 9.3% |
2018 Q1 | 3.24 Billion USD | -6.63% |
2018 Q3 | 3.24 Billion USD | -2.41% |
2018 Q4 | 3.79 Billion USD | 17.09% |
2017 Q4 | 3.47 Billion USD | 15.47% |
2017 FY | 12.44 Billion USD | 9.88% |
2017 Q2 | 3.01 Billion USD | 1.93% |
2017 Q1 | 2.95 Billion USD | -6.4% |
2017 Q3 | 3 Billion USD | -0.2% |
2016 Q3 | 2.83 Billion USD | -0.25% |
2016 Q4 | 3.15 Billion USD | 11.44% |
2016 Q1 | 2.49 Billion USD | -8.1% |
2016 FY | 11.32 Billion USD | 13.86% |
2016 Q2 | 2.84 Billion USD | 13.83% |
2015 Q2 | 2.43 Billion USD | 2.23% |
2015 Q1 | 2.37 Billion USD | -9.13% |
2015 Q3 | 2.42 Billion USD | -0.49% |
2015 Q4 | 2.71 Billion USD | 12.19% |
2015 FY | 9.94 Billion USD | 2.8% |
2014 Q1 | 2.3 Billion USD | -6.6% |
2014 Q2 | 2.36 Billion USD | 2.52% |
2014 Q4 | 2.61 Billion USD | 9.59% |
2014 Q3 | 2.38 Billion USD | 1.1% |
2014 FY | 9.67 Billion USD | 7.25% |
2013 Q3 | 2.15 Billion USD | -2.76% |
2013 FY | 9.02 Billion USD | 4.2% |
2013 Q4 | 2.46 Billion USD | 14.74% |
2013 Q1 | 2.19 Billion USD | -6.29% |
2013 Q2 | 2.21 Billion USD | 1.0% |
2012 Q3 | 2.05 Billion USD | -2.56% |
2012 FY | 8.65 Billion USD | 4.21% |
2012 Q1 | 2.16 Billion USD | -2.44% |
2012 Q2 | 2.1 Billion USD | -2.55% |
2012 Q4 | 2.33 Billion USD | 13.89% |
2011 Q1 | 2.01 Billion USD | 1.01% |
2011 Q4 | 2.21 Billion USD | 9.06% |
2011 Q3 | 2.03 Billion USD | -0.71% |
2011 Q2 | 2.04 Billion USD | 1.5% |
2011 FY | 8.3 Billion USD | 13.48% |
2010 Q2 | 1.75 Billion USD | -2.27% |
2010 FY | 7.32 Billion USD | 8.88% |
2010 Q3 | 1.76 Billion USD | 0.53% |
2010 Q4 | 1.99 Billion USD | 12.87% |
2010 Q1 | 1.79 Billion USD | -1.91% |
2009 FY | 6.72 Billion USD | 0.07% |
2009 Q2 | 1.63 Billion USD | 2.06% |
2009 Q1 | 1.6 Billion USD | -6.8% |
2009 Q4 | 1.83 Billion USD | 10.94% |
2009 Q3 | 1.65 Billion USD | 1.16% |
2008 Q4 | 1.71 Billion USD | 3.94% |
2008 Q1 | 1.63 Billion USD | -1.43% |
2008 FY | 6.71 Billion USD | 11.96% |
2008 Q3 | 1.65 Billion USD | -3.48% |
2008 Q2 | 1.71 Billion USD | 4.78% |
2007 Q4 | 1.65 Billion USD | 14.1% |
2007 Q3 | 1.45 Billion USD | -0.72% |
2007 Q2 | 1.46 Billion USD | -1.72% |
2007 Q1 | 1.48 Billion USD | 1.81% |
2007 FY | 6 Billion USD | 11.01% |
2006 FY | 5.4 Billion USD | 10.96% |
2006 Q4 | 1.46 Billion USD | 13.04% |
2006 Q3 | 1.29 Billion USD | -2.55% |
2006 Q2 | 1.32 Billion USD | 0.53% |
2006 Q1 | 1.32 Billion USD | 3.32% |
2005 FY | 4.87 Billion USD | 14.29% |
2005 Q3 | 1.17 Billion USD | -3.83% |
2005 Q2 | 1.21 Billion USD | 1.34% |
2005 Q1 | 1.2 Billion USD | 4.07% |
2005 Q4 | 1.27 Billion USD | 9.1% |
2004 FY | 4.26 Billion USD | 17.57% |
2004 Q1 | 1.03 Billion USD | 3.38% |
2004 Q3 | 1.02 Billion USD | -1.37% |
2004 Q4 | 1.15 Billion USD | 12.33% |
2004 Q2 | 1.04 Billion USD | 0.76% |
2003 Q1 | 846.9 Million USD | 2.13% |
2003 Q3 | 885.4 Million USD | -0.71% |
2003 Q2 | 891.7 Million USD | 5.29% |
2003 Q4 | 1 Billion USD | 13.09% |
2003 FY | 3.62 Billion USD | 20.38% |
2002 Q2 | 733.9 Million USD | 4.41% |
2002 Q3 | 745.6 Million USD | 1.59% |
2002 Q4 | 829.2 Million USD | 11.21% |
2002 FY | 3.01 Billion USD | 15.73% |
2002 Q1 | 702.9 Million USD | -0.9% |
2001 Q3 | 619 Million USD | -3.13% |
2001 FY | 2.6 Billion USD | 13.67% |
2001 Q1 | 634.2 Million USD | 3.56% |
2001 Q2 | 639 Million USD | 0.76% |
2001 Q4 | 709.3 Million USD | 14.59% |
2000 FY | 2.28 Billion USD | 8.83% |
2000 Q4 | 612.4 Million USD | 11.67% |
2000 Q3 | 548.4 Million USD | -3.2% |
2000 Q2 | 566.5 Million USD | 0.78% |
2000 Q1 | 562.1 Million USD | 0.54% |
1999 Q2 | 523.3 Million USD | 0.17% |
1999 Q3 | 498.9 Million USD | -4.66% |
1999 Q4 | 559.1 Million USD | 12.07% |
1999 FY | 2.1 Billion USD | 90.69% |
1999 Q1 | 522.4 Million USD | 62.54% |
1998 Q2 | 267.3 Million USD | 5.4% |
1998 Q4 | 321.4 Million USD | 23.14% |
1998 FY | 1.1 Billion USD | 12.56% |
1998 Q1 | 253.6 Million USD | -0.31% |
1998 Q3 | 261 Million USD | -2.36% |
1997 Q3 | 238.1 Million USD | -3.99% |
1997 FY | 980.1 Million USD | 7.69% |
1997 Q1 | 239.5 Million USD | -1.64% |
1997 Q2 | 248 Million USD | 3.55% |
1997 Q4 | 254.4 Million USD | 6.85% |
1996 FY | 910.1 Million USD | 4.37% |
1996 Q4 | 243.5 Million USD | 8.9% |
1996 Q3 | 223.6 Million USD | -0.8% |
1996 Q2 | 225.4 Million USD | 3.58% |
1996 Q1 | 217.6 Million USD | -2.9% |
1995 Q3 | 205.4 Million USD | -10.11% |
1995 Q4 | 224.1 Million USD | 9.1% |
1995 Q1 | 214 Million USD | 4.59% |
1995 Q2 | 228.5 Million USD | 6.78% |
1995 FY | 872 Million USD | 27.88% |
1994 FY | 681.9 Million USD | 22.36% |
1994 Q2 | 154.2 Million USD | 3.63% |
1994 Q3 | 174.3 Million USD | 13.04% |
1994 Q4 | 204.6 Million USD | 17.38% |
1994 Q1 | 148.8 Million USD | 2.48% |
1993 Q3 | 136.9 Million USD | -2.21% |
1993 Q1 | 135.2 Million USD | 4.0% |
1993 Q2 | 140 Million USD | 3.55% |
1993 FY | 557.3 Million USD | 16.81% |
1993 Q4 | 145.2 Million USD | 6.06% |
1992 Q3 | 117.4 Million USD | 0.26% |
1992 Q2 | 117.1 Million USD | 4.0% |
1992 Q4 | 130 Million USD | 10.73% |
1992 Q1 | 112.6 Million USD | 11.93% |
1992 FY | 477.1 Million USD | 30.78% |
1991 Q4 | 100.6 Million USD | 11.9% |
1991 FY | 364.8 Million USD | 30.01% |
1991 Q3 | 89.9 Million USD | 1.47% |
1991 Q1 | 85.7 Million USD | 10.44% |
1991 Q2 | 88.6 Million USD | 3.38% |
1990 Q4 | 77.6 Million USD | 14.79% |
1990 Q3 | 67.6 Million USD | -0.29% |
1990 Q2 | 67.8 Million USD | 0.3% |
1990 FY | 280.6 Million USD | 24.21% |
1990 Q1 | 67.6 Million USD | 11.74% |
1989 FY | 225.9 Million USD | 26.48% |
1989 Q3 | 54.7 Million USD | -3.7% |
1989 Q2 | 56.8 Million USD | 5.38% |
1989 Q1 | 53.9 Million USD | 13.0% |
1989 Q4 | 60.5 Million USD | 10.6% |
Name | Revenue | Revenue Difference |
---|---|---|
Abbott Laboratories | 40.1 Billion USD | 48.894% |
Allurion Technologies Inc. | 53.46 Million USD | -38237.666% |
Artivion, Inc. | 354 Million USD | -5690.33% |
Avanos Medical, Inc. | 673.3 Million USD | -2944.408% |
Butterfly Network, Inc. | 65.9 Million USD | -31004.704% |
Butterfly Network, Inc. | 65.9 Million USD | -31004.704% |
Bio-Rad Laboratories, Inc. | 2.67 Billion USD | -667.353% |
Boston Scientific Corporation | 14.24 Billion USD | -43.947% |
Perspective Therapeutics, Inc. | 7.1 Million USD | -288441.667% |
CONMED Corporation | 1.24 Billion USD | -1551.794% |
Edwards Lifesciences Corporation | 6 Billion USD | -241.36% |
Paragon 28, Inc. | 216.38 Million USD | -9372.755% |
Glaukos Corporation | 314.71 Million USD | -6413.277% |
Globus Medical, Inc. | 1.56 Billion USD | -1206.874% |
Inspire Medical Systems, Inc. | 624.79 Million USD | -3180.735% |
Integer Holdings Corporation | 1.59 Billion USD | -1183.794% |
Medtronic plc | 32.36 Billion USD | 36.664% |
Nevro Corp. | 425.17 Million USD | -4721.085% |
Owlet, Inc. | 54.01 Million USD | -37852.231% |
Penumbra, Inc. | 1.05 Billion USD | -1836.474% |
Vicarious Surgical Inc. | - USD | -Infinity% |
Smith & Nephew plc | 5.54 Billion USD | -269.4% |
Sonendo, Inc. | 43.86 Million USD | -46629.739% |
STERIS plc | 5.13 Billion USD | -298.895% |
Vapotherm, Inc. | 68.66 Million USD | -29750.442% |
Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | -177.217% |